7. REFERENCES

Ashok, PW, Penney GC, Flett GMM, Templeton, A. An effective Regimen for Early Medical Abortion:  A Report of 200 Consecutive Cases. Hum Reprod 1998;13:2962-2965.  http://goo.gl/XWLvH

Boersma AA, Meyboom-de Jong B, Kleiverda G. Mifepristone followed by home administration of buccal misoprostol for medical abortion up to 70 days of amenorrhoea in a general practice in Curaçao. Eur J Contracept Reprod Health Care. 2011 Apr;16(2):61-6. http://goo.gl/tHwKax

Bracken H, Dabash R, Tsertsvadze G, et al. A two-pill sublingual misoprostol outpatient regimen following mifepristone for medical abortion through 70 days’ LMP: a prospective comparative open-label trial. Contraception. 2014 Mar;89(3):181-6. http://goo.gl/ze0c6k

Chai J, Wong CY, Ho PC. A randomized clinical trial comparing the short-term side effects of sublingual and buccal routes of misoprostol administration for medical abortions up to 63 days’ gestation. Contraception. 2013 Apr;87(4):480-5. http://goo.gl/5MDxnW

Creinin MD, Fox MC, Teal S, Chen A, Schaff EA, Meyn LA; MOD Study Trial Group.  A randomized comparison of misoprostol 6 to 8 hours versus 24 hours after mifepristone for abortion.  Obstet Gynecol 2004 May;103(5 Pt 1):851-859.  http://goo.gl/EnwDD

Creinin MD, Schreiber CA, Bednarek P, Lintu H, Wagner MS, Meyn LA. Mifepristone and misoprostol administered simultaneously versus 24 hours apart for abortion: a randomized controlled trial. Obstet Gynecol. 2007 Apr;109(4):885-94.  http://goo.gl/UWAie

Danco: FDA Package Label; urrent Mifeprex materials March 2016.  http://www.earlyoptionpill.com

Davis A, Westhoff C, De Nonno L. Bleeding patterns after early abortion with mifepristone and misoprostol or manual vacuum aspiration.  J Am Med Womens Assoc 2000;55(3 Suppl):141-4.  http://goo.gl/RAZWK

Fjerstad M, Trussell J, Lichtenberg ES, Sivin I, Cullins V. Severity of infection following the introduction of new infection control measures for medical abortion. Contraception. 2011 Apr;83(4):330-5.  http://goo.gl/PXlnh

Gatter M, Cleland K, Nucatola DL, Efficacy and safety of medical abortion using mifepristone and buccal misoprostol through 63 days. Contraception 2015 April 91(4): 269-73. http://goo.gl/lAK88G

Grossman D, Grindlay K, Buchacker T, Lane K, Blanchard K. Effectiveness and acceptability of medical abortion provided through telemedicine. Obstet Gynecol. 2011 Aug;118(2 Pt 1):296-303. http://goo.gl/sPSaIJ

Gynuity Health Projects. Consensus Statement: Instructions for Use: Abortion Induction with Misoprostol Alone in Pregnancies Through 9 Weeks’ LMP. October 2013. http://goo.gl/bBkerS

Ipas Clinical Updates in Reproductive Health. Published 2016. http://goo.gl/s2d5Hc

Jones RK, Jerman J, Abortion incidence and service availability in the United States, 2011, Perspectives on Sexual and Reproductive Health, 2014, 46(1):3-14 http://goo.gl/sOkcwA

Meites E, Zane S, Gould C; C. sordellii Investigators. Fatal Clostridium sordellii infections after medical abortions. N Engl J Med. 2010 Sep 30;363(14):1382-3.  http://goo.gl/ptOFB

Middleton T, Schaff E, Fielding SL, et al. Randomized trial of mifepristone and misoprostol for abortion through 56 days of LMP. Contraception 2005;72:328-332.  http://goo.gl/hGXes

NAF Online 2016: http://goo.gl/xFvN1W

National Abortion Federation Clinical Policy Guidelines 2015.  https://goo.gl/nqs3hh

Oppegaard KS, Qvigstad E, Fiala C, Heikinheimo O, Benson L, Gemzell-Danielsson K. Clinical follow-up compared with self-assessment of outcome after medical abortion: a multicentre, non-inferiority, randomised, controlled trial. Lancet. 2015 Feb 21;385(9969):698-704. http://goo.gl/fTxe2V

Raymond EG, Weaver MA, Tan YL, et al. Effect of Immediate Compared With Delayed Insertion of Etonogestrel Implants on Medical Abortion Efficacy and Repeat Pregnancy: A Randomized Controlled Trial. Obstet Gynecol. 2016 Feb;127(2):306-12. http://goo.gl/ML5XId

Reeves MF, Fox MC, Lohr PA, Creinin MD. Endometrial Thickness Following Medical Abortion Is not Predictive of Subsequent Surgical Intervention. Ultrasound Obstet Gynecol. 2009;34(1):104-9. http://goo.gl/nWW3Al

Reeves MF, Kudva A, Creinin MD. Medical abortion outcomes after a second dose of misoprostol for persistent gestational sac. Contraception. 2008 Oct;78(4):332-5. http://goo.gl/NdEyFD

Reeves MF, Monmaney JA, Creinin MD. Predictors of uterine evacuation following early medical abortion with mifepristone and misoprostol. Contraception. 2016 Feb;93(2):119-25. http://goo.gl/Fvh0Fg

Sääv I, Stephansson O, Gemzell-Danielsson K. Early versus delayed insertion of intrauterine contraception after medical abortion – a randomized controlled trial. PLoS One. 2012;7(11):e48948. http://goo.gl/5o3Uk8

Sanhueza Smith P, Peña M, Dzuba IG, et al. Safety, efficacy and acceptability of outpatient mifepristone-misoprostol medical abortion through 70 days since last menstrual period in public sector facilities in Mexico City. Reprod Health Matters. 2015 Feb;22(44 Suppl 1):75-82. http://goo.gl/QXEZnA

Schaff EA, Eisinger SH, Stadalius LS, Franks P, Gore BZ, Poppema S.  Low-dose mifepristone 200 mg and vaginal misoprostol for abortion.  Contraception 1999 Jan;59(1):1-6.  http://goo.gl/jzk3F

Schaff EA, Fielding SL, Westhoff C.  Randomized trial of oral versus vaginal misoprostol 2 days after mifepristone 200 mg for abortion up to 63 days of pregnancy. Contraception 2002 Oct;66(4):247-250. http://goo.gl/LMcUJ

Seeber BE, Barnhart KT. Suspected ectopic pregnancy. Obstet Gynecol. 2006 Feb;107(2 Pt 1):399-413. Review. Erratum in: Obstet Gynecol. 2006 Apr;107(4):955. http://goo.gl/Li5tzr

Society of Family Planning Clinical Guideline. Medical management of first-trimester abortion. Contraception 89(3) 2014, pp. 148–161. http://goo.gl/BJiETT

Tang OS, Chan CC, Ng EH, Lee SW, Ho PC. A prospective, randomized, placebo-controlled trial on the use of mifepristone with sublingual or vaginal misoprostol for medical abortions of less than 9 weeks gestation. Hum Reprod. 2003 Nov;18(11):2315-8. http://goo.gl/RMgL5k

Trussell J, Nucatola D, Fjerstad M, Lichtenberg ES. Reduction in infection-related mortality since modifications in the regimen of medical abortion. Contraception. 2014 Mar;89(3):193-6. http://goo.gl/U9ioul

von Hertzen H, Piaggio G, Huong NT, et al. Efficacy of two intervals and two routes of administration of misoprostol for termination of early pregnancy: a randomised controlled trial. Lancet. Jun 9 2007;369(9577):1938-1946. http://goo.gl/P7xGtI

Winikoff B, Dzuba IG, Chong E, et al. Extending outpatient medical abortion services through 70 days of gestational age. Obstet Gynecol. 2012 Nov;120(5):1070-6. http://goo.gl/cLx0eM

Comments are closed.